Company | Aon plc |
Ticker | AON US |
Reporting Period | Q2 2026 (quarter ending June 30, 2026) |
Earnings Date | July 29, 2026 — 8:30 AM ET |
Prepared | July 28, 2026 |
Last Earnings | May 1, 2026 (Q1 2026) |
Sector ETF (Chart) | KIE (SPDR S&P Insurance ETF) |
Key Takeaway: The setup into Q2 2026 is modestly constructive — consensus sits at a manageable bar with organic growth expected at ~5% and adjusted EPS of ~$3.80 — but the single biggest swing factor is whether Commercial Risk can sustain its 6%+ organic growth streak despite accelerating property rate headwinds flagged by every peer that has already reported.
Aon enters Q2 2026 with momentum from a strong Q1 beat (5% organic, 70 bps margin expansion, 14% EPS growth) and a reaffirmed full-year guidance framework of mid-single-digit-or-greater organic growth, 70–80 bps of margin expansion, and double-digit free cash flow growth. The bar for Q2 is not particularly elevated — consensus organic growth of ~5% is in line with the low end of guidance, and the adjusted EPS estimate of ~$3.80 represents a modest step-up from the prior-year $3.49 — but the quarter carries a specific headwind: management guided explicitly at Q1 earnings that April 1 reinsurance renewals would see rates down 15–20% in both the U.S. and Japan, partially offset by ~10% higher demand, creating a known drag on the Reinsurance segment. Peer commentary from Marsh McLennan (Q2 reported July 21) and Brown & Brown (Q2 reported July 28) confirms that property cat rates continued to decline 15–35% in Q2, while casualty remained firm and new business activity was broadly healthy — a mixed but navigable backdrop for Aon's diversified book. Estimate revisions have drifted modestly lower since Q1 earnings (Q2 EPS consensus slipped from ~$3.81 to ~$3.80), suggesting the Street has already absorbed the reinsurance headwind without panic. The stock has rallied ~22% since the Q1 print (from $311.51 to $367.17 as of July 27), driven almost entirely by multiple re-rating rather than estimate upgrades, which means the stock is pricing in execution rather than upside surprise. The wildcard is the data center revenue pipeline, which management described as tracking 3x higher than last year — any incremental color on conversion timing or capacity expansion beyond the current $3.5B DCLP facility could be the catalyst that moves the stock on print day.
Key Takeaway: Consensus is a manageable, low-to-mid bar heading into Q2 — organic growth at ~5% sits at the floor of guidance and EPS at ~$3.80 is a modest step-up from prior year. The bigger swing factor is Commercial Risk organic growth, where any print at or above 6% (the four-quarter streak) would be a positive signal, while a deceleration below 5% driven by reinsurance rate pressure would disappoint.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | FY 2026 Guidance | Consensus vs. Guidance |
Total Revenue ($B) | $5.034B | $4.155B | $4.274B | +2.9% YoY | Mid-single-digit or greater organic growth (no absolute revenue guide) | N/A (no absolute revenue guidance) |
Organic Revenue Growth (%) | 5.0% | 6.0% | ~5.0% | -100 bps YoY | Mid-single-digit or greater (i.e., ≥5%) | At floor of guidance range |
Adj. EPS — Diluted Operating (Continuing Ops) | $6.48 | $3.49 | ~$3.80 | +8.9% YoY | Strong earnings growth; FY2026 consensus ~$19.10 | FY consensus ~$19.10 vs. implied guidance of strong growth |
Free Cash Flow ($B) | $0.363B | $0.732B | ~$0.748B | +2.2% YoY | Double-digit FCF growth for FY2026; FY guide ~$4.3B (before $300M tax impact) | FY consensus $3.78B vs. guided ~$4.3B; Q2 consensus below prior year |
Sources: Visible Alpha Consensus and Actuals Data — Total Revenue: VA IS/RV; Organic Revenue Growth: VA RV; Adj. EPS (Diluted Operating): VA IS; Free Cash Flow: VA CF. Q2 2026 consensus as of July 28, 2026.
Quarter | Reported | Consensus | Surprise (bps) | Result |
Q2 2024 | 6.0% | N/A — not in VA for that period | N/A | N/A |
Q3 2024 | 7.0% | 4.9% | +210 bps | Beat |
Q4 2024 | 6.0% | 5.4% | +60 bps | Beat |
Q1 2025 | 5.0% | 6.1% | -110 bps | Miss |
Q2 2025 | 6.0% | 4.8% | +120 bps | Beat |
Q3 2025 | 7.0% | 5.4% | +160 bps | Beat |
Q4 2025 | 5.0% | 5.2% | -20 bps | In-Line / Slight Miss |
Q1 2026 | 5.0% | 5.1% | -10 bps | In-Line |
Pattern: Aon has beaten organic growth consensus in 5 of the last 7 quarters with available data, with the two misses being modest (10–20 bps). The Street has historically underestimated Aon's Commercial Risk momentum, though the Q1 2025 miss (when consensus was set too high at 6.1%) shows the risk of a high bar. Source: Visible Alpha Consensus and Actuals Data.
Quarter | Reported ($) | Consensus ($) | Surprise (%) | Result |
Q2 2024 | $3.49 | $3.40 | +2.7% | Beat |
Q3 2024 | $2.72 | $2.47 | +10.1% | Beat |
Q4 2024 | $4.42 | $4.24 | +4.2% | Beat |
Q1 2025 | $5.67 | $6.02 | -5.8% | Miss |
Q2 2025 | $3.49 | $3.40 | +2.7% | Beat |
Q3 2025 | $3.05 | $2.91 | +4.8% | Beat |
Q4 2025 | $4.85 | $4.74 | +2.3% | Beat |
Q1 2026 | $6.48 | $6.36 | +1.9% | Beat |
Pattern: Aon has beaten adjusted EPS consensus in 7 of the last 8 quarters, with the sole miss in Q1 2025 driven by a one-time elevated consensus bar. Beat magnitude has been consistent at 2–10%, suggesting the Street tends to set a slightly conservative EPS bar. Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Guidance has been fully reaffirmed since Q1 earnings with no formal revisions, but management's tone has grown incrementally more confident on capital allocation — the $7.5B buyback authorization approved June 26 is the most significant post-earnings development and signals conviction in intrinsic value well above current market price.
Metric | Initial Guidance (Q1 2026 Earnings — May 1, 2026) | Revised Guidance | Current Consensus | Note |
Organic Revenue Growth (FY2026) | Mid-single-digit or greater | — | ~5.0% (FY2026) | Reaffirmed at Morgan Stanley Financials Conference (June 9, 2026); management expressed continued confidence in mid-single-digit or greater growth in all pricing environments |
Adj. Operating Margin Expansion (FY2026) | 70–80 bps expansion | — | Consensus implies ~70 bps expansion | Unchanged; ABS leverage (40–50 bps) + restructuring savings ($100M / ~50 bps) partially offset by fiduciary income headwind (~20 bps) |
Free Cash Flow (FY2026) | Double-digit FCF growth; ~$4.3B (before $300M tax impact from NFP Wealth sale) | — | ~$3.78B (FY2026 consensus) | Consensus sits below guided level; gap likely reflects Street conservatism on timing of FCF conversion; no formal revision |
Share Repurchases (FY2026) | At least $1B for the year; $500M deployed in Q1 (2x prior 8-quarter average) | ↑ Board approved additional $7.5B buyback authorization (June 26, 2026 — 8-K) | N/A — not modeled in consensus | ↑ Significant upgrade: new $7.5B authorization added to ~$0.8B remaining; signals management conviction that stock trades well below intrinsic value |
Leverage (FY2026) | Objective: at least 2.9x; Q1 actual: 2.7x (below objective) | — | N/A | At Morgan Stanley conference (June 9), CFO noted leverage is now below stated objectives; M&A pipeline strong but private market valuations not yet fully reflecting public market conditions — preference for buybacks near-term |
Restructuring Savings (FY2026) | $100M savings in 2026; advancing toward $450M total by 2027 | — | N/A | Unchanged; 2026 is final year of restructuring investment |
Effective Tax Rate (FY2026) | 19.5%–20.5% | — | N/A | Unchanged |
Revenue-Generating Talent Growth (FY2026) | 4%–8% net increase in revenue-generating population | — | N/A | Unchanged; 2024/2025 cohorts contributed 75 bps to Q1 organic growth with compounding effect building |
Key Takeaway: Estimates for Q2 2026 and FY2026 have been essentially flat since Q1 earnings — a sign the Street has absorbed the known reinsurance headwind without cutting numbers. The FY2026 FCF consensus ($3.78B) remains well below management's guided ~$4.3B, representing the largest gap and a potential source of upside if conversion improves in H2.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (May 8, 2026) | Current Consensus (July 28, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Earnings Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Organic Revenue Growth — Q2 2026 | 5.02% | 5.01% | -0.2% | Mid-single-digit or greater (≥5%) | Unchanged | — | At floor of guidance |
Organic Revenue Growth — FY2026 | 4.98% | 4.99% | +0.2% | Mid-single-digit or greater (≥5%) | Unchanged | — | Just below floor of guidance |
Adj. EPS (Diluted Operating) — Q2 2026 | $3.81 | $3.80 | -0.3% | Strong earnings growth (no specific Q2 EPS guide) | Unchanged | — | N/A (no specific Q2 EPS guidance) |
Adj. EPS (Diluted Operating) — FY2026 | $19.11 | $19.10 | -0.1% | Strong earnings growth (no specific FY EPS guide) | Unchanged | — | N/A (no specific FY EPS guidance) |
Free Cash Flow — Q2 2026 | $0.888B | $0.748B | -15.8% | Double-digit FCF growth for FY2026 | Unchanged | — | Q2 consensus well below prior-year $0.732B; FCF is lumpy by quarter |
Free Cash Flow — FY2026 | $3.935B | $3.775B | -4.1% | ~$4.3B (before $300M NFP Wealth tax impact) | Unchanged | — | Consensus ~12% below guided level; largest gap vs. guidance across all KPIs |
Estimates have been remarkably stable since Q1 earnings — organic growth and EPS estimates moved less than 0.3% in either direction, confirming the Street has fully priced in the known reinsurance rate headwind. The FCF gap (consensus $3.78B vs. guided ~$4.3B) is the most notable divergence and likely reflects Street conservatism on the $300M NFP Wealth tax payment timing; any H2 FCF acceleration commentary would be a positive catalyst. Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: AON has rallied ~22% since the Q1 print (May 1 → July 27), dramatically outperforming both KIE (+14%) and the S&P 500 (+3%). Virtually all of the outperformance is multiple re-rating — EV/EBITDA expanded from ~12.8x to ~14.4x over the past month — driven by the $7.5B buyback authorization and growing conviction in the data center opportunity, not estimate upgrades. The stock is no longer cheap on a near-term basis, raising the execution bar for the print.
Chart: AON vs. KIE (SPDR S&P Insurance ETF) vs. S&P 500 — Indexed to 100 at May 1, 2026 (Q1 2026 Earnings Date). Prices indexed to 100 at close on May 1, 2026. Last data point: July 27, 2026 (last available regular-session close before earnings). Note: July 29, 2026 earnings-day price not included as the session was not yet complete at time of preparation.
Date | AON (Indexed) | KIE (Indexed) | SPY (Indexed) |
May 1, 2026 (Base) | 100.0 | 100.0 | 100.0 |
May 18, 2026 | 104.8 | 102.3 | 102.5 |
Jun 9, 2026 (Morgan Stanley Conference) | 106.4 | 100.3 | 102.3 |
Jun 26, 2026 ($7.5B Buyback Authorization) | 105.5 | 107.5 | 101.2 |
Jul 2, 2026 | 114.7 | 112.8 | 103.3 |
Jul 13, 2026 | 117.9 | 113.5 | 104.0 |
Jul 27, 2026 (Last Close) | 117.9 | 114.0 | 102.6 |
Stock Performance Decomposition (NTM EV/EBITDA): Over the past month, AON's price rose +16.0% while NTM EV/EBITDA expanded +12.6% (from 12.82x to 14.42x), confirming that multiple re-rating — not estimate upgrades — drove the bulk of the move. Over 12 months, the stock is up only +2.3% as multiple compression (-9.4%, from 15.92x to 14.42x) offset underlying earnings growth. The recent re-rating reflects the $7.5B buyback authorization and renewed data center conviction, but leaves the stock more dependent on execution at the print. Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: The $7.5B share repurchase authorization (June 26) is the most consequential post-Q1 development — it signals management's conviction that the stock is materially undervalued and provides a multi-year capital return floor that the Street has not yet fully modeled.
Key Takeaway: Peer commentary from MMC (Q2 reported), BRO (Q2 reported), and AJG (pre-Q2 investor meeting) collectively confirms that new business momentum and casualty pricing remain constructive, while property cat rate declines of 15–35% are the dominant headwind — a known and already-guided risk for Aon's Reinsurance segment. The net read-through is mixed-to-slightly-positive for Aon's diversified book.
Scope note: Only commentary explicitly about Q2 2026 current-quarter trading, pricing, or forward outlook is included below. Prior-quarter result discussions (e.g., Q1 2026 results reported in April/May) are excluded. Sources: MMC Q2 2026 Earnings Call (July 21, 2026); BRO Q2 2026 Earnings Call (July 28, 2026); AJG Pre-Q2 2026 Investor Meeting with Management (June 17, 2026).
Key Takeaway: Insider activity since Q1 earnings is limited to a single 10b5-1 planned sale by the General Counsel — a routine, pre-scheduled transaction with no directional signal. No open-market buys or discretionary sales were filed. The absence of discretionary selling ahead of earnings is a mild positive.
Name | Title | Transaction Type | Shares / Value | Transaction Date | Note |
Darren Zeidel | General Counsel | 10b5-1 Planned Sale | 600 shares / ~$717,750 (Form 144 filed July 28, 2026) | July 7, 2026 | Pre-scheduled 10b5-1 plan sale; not discretionary. Second Form 144 filing by Zeidel in July (prior filing July 17 for ~$725,500). Routine in nature; no directional signal. |
Source: SEC Form 4 and Form 144 filings. Open-market buys and sells (Form 4 codes P/S) and 10b5-1 plan initiations only. No open-market buys or discretionary sales were filed by any AON insider in the 60 days since Q1 earnings (May 1 – July 28, 2026).